rhenium has been researched along with Neoplasms in 60 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (5.00) | 18.7374 |
1990's | 12 (20.00) | 18.2507 |
2000's | 20 (33.33) | 29.6817 |
2010's | 19 (31.67) | 24.3611 |
2020's | 6 (10.00) | 2.80 |
Authors | Studies |
---|---|
Banerjee, S; He, J; Ouyang, A; Xie, J; Zhang, P; Zhang, Q; Zhu, J | 1 |
Li, Y; Liu, B; Miao, Y; Ouyang, R; Qi, Q; Ruiz, MEL; Silva, DZ; Wang, Q | 1 |
Cheng, R; Kan, D; Pan, J; Sun, SK; Wang, J; Wang, X; Zhang, X; Zhao, F | 1 |
Hao, L; Ji, LN; Mao, ZW; Pan, ZY; Rao, LS; Tan, CP; Zhang, H; Zheng, Y | 1 |
Delsuc, N; Kiew, LV; Liew, HS; Low, ML; Madheswaran, T; Mai, CW; Zulkefeli, M | 1 |
Makgopa, K; Manicum, AE; Mkhatshwa, M; Moremi, JM | 1 |
Chang, KH; Chen, YT; Chou, PT; Chu, CY; Grachova, EV; Jänis, J; Kisel, KS; Koshevoy, IO; Liu, TM; Shakirova, JR; Shen, YF; Thangavel, MK; Tsai, MR; Tunik, SP; Wu, CH; Wu, PC; Zhang, Z | 1 |
Jay, M; Kim, J; Lu, X; Narayan, RJ | 1 |
Barr, MP; Baskin, JM; Boros, E; Knopf, KM; MacMillan, SN; Murphy, BL; Wilson, JJ | 1 |
Fernández-Moreira, V; Gimeno, MC; Luengo, A; Marzo, I | 1 |
Honda, T; Ojima, I; Vineberg, JG; Wang, T | 1 |
Cao, Q; Gan, Z; Hao, L; Ji, LN; Li, Z; Mao, ZW; Tong, YX; Yang, J; Zhang, H; Zhou, D | 1 |
Chen, G; Chen, R; Gong, T; Kong, KV; Lin, D; Qiu, S; Tseng, CY; Wu, Q | 1 |
Casari, I; Desai, NM; Falasca, M; Massi, M; Simpson, PV | 1 |
Ferrari, S; Gasser, G; Heier, J; Leonidova, A; Pierroz, V; Rubbiani, R | 1 |
Gasser, G; Leonidova, A | 1 |
Ferreira, VF; Gano, L; Mendes, F; Morais, GR; Nunes, P; Oliveira, MC; Outeiro, TF; Palma, E; Paulo, A; Santos, I; Silva, F; Vicente Miranda, H | 1 |
Feron, O; Gallez, B; Lucas, S; Masereel, B; Michiels, C; Vander Borght, T | 1 |
Cheng, CN; Hsu, WC; Hwang, JJ; Lee, TW | 1 |
Brust, P; Chen, X; Chen, Y; Deuther-Conrad, W; Dong, C; Jia, B; Jia, H; Li, D; Liu, B; Steinbach, J; Wang, X | 1 |
Chen, MH; Hao, L; Ji, LN; Mao, ZW; Tan, CP; Ye, RR | 1 |
Arteaga de Murphy, C; Ferro-Flores, G | 1 |
Chen, Y; Xiong, QF | 1 |
Blanc, A; Bläuenstein, P; García-Garayoa, E; Maes, V; Schubiger, PA; Tourwé, D | 1 |
Kotzerke, J; Oehme, L | 1 |
Dewit, MA; Luyt, LG; Rosita, D | 1 |
Huang, DD; Li, QW; Liu, GY; Luo, CX; Qin, ZX; Xie, GF; Zheng, L | 1 |
Kotzerke, J; Luboldt, W; Matzky, C; Pinkert, J; Wunderlich, G | 1 |
Hashimoto, K; Kawashima, H; Kimura, H; Kinuya, S; Odani, A; Ogawa, K; Onoguchi, M; Saji, H; Shiba, K | 1 |
Han, Y; Li, Z; Ma, Y; Shen, H; Yin, D; Yu, J; Zhou, W | 1 |
Bolzati, C; Carta, D; Refosco, F; Salvarese, N | 1 |
Dash, A; Knapp, FF; Pillai, MR | 1 |
Cerecetto, H; Fernández, S; Giglio, J; Rey, AM | 1 |
Boerman, OC; Corstens, FH; Frielink, C; Goldenberg, DM; Oyen, WJ; Postema, EJ; Raemaekers, JM | 1 |
Drews, A; Kotzerke, J; Wunderlich, G | 1 |
Spicer, J | 1 |
Andreeff, M; Behge, K; Kotzerke, J; Schönmuth, T; Wunderlich, G | 1 |
Barbos, D; Fessi, H; Hamoudeh, M; Paunoiu, C; Salim, H | 1 |
Buono, S; Burgio, N; Fessi, H; Hamoudeh, M; Hiltbrand, E; Maciocco, L; Mehier-Humbert, S | 1 |
Müller, C; Schibli, R; Schubiger, PA | 1 |
Furudate, M; Itoh, K; Kamada, T; Mizoe, J; Saitoh, C; Shinohara, M; Tsujii, H | 1 |
Clarke, SE | 1 |
Wagner, HN | 1 |
Lewington, VJ | 1 |
Ben-Josef, E; Porter, AT | 1 |
Buchsbaum, DJ; Khazaeli, MB; Qin, H; Safavy, A | 1 |
Iznaga-Escobar, N | 2 |
Breitz, HB; Fisher, DR; Wessels, BW | 1 |
DeNardo, GL | 1 |
Knapp, FF | 1 |
Breitz, HB | 1 |
Emfietzoglou, D; Kostarelos, K; Sgouros, G | 1 |
Adolf, GR; Heider, KH; Ostermann, E; Patzelt, E; Siegmund, M; Snow, GB; Sproll, M; van Dongen, GA; Verel, I | 1 |
Mikheev, NB | 1 |
Appelbaum, JW; Bjorn, MJ; Breitz, HB; Fer, MF; Foisie, DC; Ratliff, BA; Seiler, CA; Vanderheyden, JL; Weiden, PL; Wolf, SB | 1 |
Goldenberg, DM; Griffiths, GL | 1 |
Bisunadan, MM; Blower, PJ; Clarke, SE; Singh, J; Went, MJ | 1 |
Quadri, SM; Wessels, BW | 1 |
18 review(s) available for rhenium and Neoplasms
Article | Year |
---|---|
Recent Development of Rhenium-Based Materials in the Application of Diagnosis and Tumor Therapy.
Topics: Humans; Ligands; Luminescence; Neoplasms; Oxidation-Reduction; Radioisotopes; Rhenium | 2023 |
Recent Emergence of Rhenium(I) Tricarbonyl Complexes as Photosensitisers for Cancer Therapy.
Topics: Animals; Antineoplastic Agents; Carbon; Cell Line, Tumor; Coordination Complexes; Drug Combinations; Humans; Mice; Neoplasms; Oxygen; Photochemotherapy; Photons; Photosensitizing Agents; Reactive Oxygen Species; Rhenium | 2020 |
Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics.
Topics: Animals; Humans; Magnetite Nanoparticles; Neoplasms; Organometallic Compounds; Rhenium; Theranostic Nanomedicine | 2021 |
Metal-based antitumor compounds: beyond cisplatin.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Copper; Drug Discovery; Gold; Humans; Iridium; Iron; Metals; Neoplasms; Organometallic Compounds; Rhenium; Rhodium; Ruthenium | 2019 |
Underestimated potential of organometallic rhenium complexes as anticancer agents.
Topics: Antineoplastic Agents; Humans; Neoplasms; Organometallic Compounds; Rhenium | 2014 |
Pharmacokinetics and dosimetry of 188 Re-pharmaceuticals.
Topics: Bone Neoplasms; Carcinoma, Hepatocellular; Hematopoietic Stem Cell Transplantation; Humans; Liver Neoplasms; Microspheres; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium | 2008 |
Review: Deoxyglucose compounds labeled with isotopes different from 18-fuoride: is there a future in clinical practice?
Topics: Animals; Deoxyglucose; Diagnostic Imaging; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Mice; Neoplasm Transplantation; Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Rhenium; Technetium; Tomography, Emission-Computed, Single-Photon | 2008 |
Chelating systems for (99m)Tc/(188)Re in the development of radiolabeled peptide pharmaceuticals.
Topics: Amino Acid Sequence; Animals; Chelating Agents; Humans; Models, Molecular; Molecular Sequence Data; Neoplasms; Peptides; Radiopharmaceuticals; Receptors, Peptide; Rhenium; Solid-Phase Synthesis Techniques; Technetium | 2012 |
Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
Topics: Adsorption; Antibodies, Monoclonal; Arthritis, Rheumatoid; Bone Neoplasms; Carcinoma, Hepatocellular; Chromatography; Coronary Disease; Drug Combinations; Equipment Design; Humans; Iodized Oil; Liver Neoplasms; Musculoskeletal Pain; Neoplasms; Organometallic Compounds; Palliative Care; Peptides; Radioimmunotherapy; Radioisotopes; Radionuclide Generators; Radiopharmaceuticals; Rhenium; Skin Neoplasms; Succimer | 2012 |
Technology evaluation: nimotuzumab, the Center of Molecular Immunology/YM BioSciences/Oncoscience.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Humans; Mice; Neoplasms; Radioisotopes; Rats; Rhenium | 2005 |
Brachytherapy: state of the art and possible improvements.
Topics: Brachytherapy; Drug Delivery Systems; Female; Holmium; Humans; Male; Necrosis; Neoplasms; Neutrons; Particle Accelerators; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium | 2007 |
Radionuclide therapy in oncology.
Topics: 3-Iodobenzylguanidine; Antibodies, Monoclonal; Bone Neoplasms; Brachytherapy; Humans; Iodine Radioisotopes; Iodobenzenes; Neoplasms; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium Radioisotopes; Thyroid Neoplasms | 1994 |
Cancer therapy using bone-seeking isotopes.
Topics: Bone Neoplasms; Humans; Neoplasms; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Radiotherapy Dosage; Rhenium; Samarium; Strontium; Tin Radioisotopes | 1996 |
Radioisotopes in the treatment of bone metastases.
Topics: Bone and Bones; Humans; Neoplasm Metastasis; Neoplasms; Palliative Care; Phosphorus Radioisotopes; Radioisotopes; Rhenium; Samarium; Strontium Radioisotopes; Treatment Outcome | 1997 |
188Re-direct labeling of monoclonal antibodies for radioimmunotherapy of solid tumors: biodistribution, normal organ dosimetry, and toxicology.
Topics: Animals; Antibodies, Monoclonal; Humans; Isotope Labeling; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiometry; Rhenium; Tissue Distribution | 1998 |
Rhenium-188--a generator-derived radioisotope for cancer therapy.
Topics: Half-Life; Humans; Neoplasms; Radioisotopes; Radiopharmaceuticals; Rhenium | 1998 |
Direct radiolabeling of monoclonal antibodies with rhenium-188 for radioimmunotherapy of solid tumors--a review of radiolabeling characteristics, quality control and in vitro stability studies.
Topics: Animals; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Chromatography, Paper; Drug Stability; Humans; Immunoconjugates; In Vitro Techniques; Mice; Neoplasms; Quality Control; Radioimmunotherapy; Radioisotopes; Rhenium | 2001 |
Radioactive colloidal solutions and suspensions for medical use.
Topics: Colloids; Drug Stability; Gallium Radioisotopes; Gold Colloid, Radioactive; Humans; Indium; Iodine Radioisotopes; Isotope Labeling; Lung Diseases; Mononuclear Phagocyte System; Neoplasms; Phosphorus Radioisotopes; Quaternary Ammonium Compounds; Radioisotopes; Radionuclide Imaging; Rhenium; Serum Albumin, Radio-Iodinated; Suspensions; Technetium; Yttrium Radioisotopes | 1976 |
2 trial(s) available for rhenium and Neoplasms
Article | Year |
---|---|
Clinical experience with rhenium-186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibodies, Monoclonal; Drug Evaluation; Female; Humans; Male; Mice; Middle Aged; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium | 1992 |
Radioimmunotherapy of cancer: arming the missiles.
Topics: Animals; Antibodies, Monoclonal; Drug Evaluation; Humans; Mice; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium | 1992 |
40 other study(ies) available for rhenium and Neoplasms
Article | Year |
---|---|
An ultrasound activated cyanine-rhenium(I) complex for sonodynamic and gas synergistic therapy.
Topics: Cell Line, Tumor; Ferroptosis; Humans; Neoplasms; Rhenium; Ultrasonic Therapy; Ultrasonography | 2022 |
Rhenium Sulfide Nanoparticles as a Biosafe Spectral CT Contrast Agent for Gastrointestinal Tract Imaging and Tumor Theranostics in Vivo.
Topics: Animals; Cell Line, Tumor; Contrast Media; Gastrointestinal Tract; Hyperthermia, Induced; Mice; Nanoparticles; Neoplasms; Phototherapy; Rhenium; Sulfides; Theranostic Nanomedicine; Tomography, X-Ray Computed | 2019 |
Recoding the Cancer Epigenome by Intervening in Metabolism and Iron Homeostasis with Mitochondria-Targeted Rhenium(I) Complexes.
Topics: Animals; Apoptosis; Cell Line, Tumor; Coordination Complexes; Deferasirox; Drug Evaluation, Preclinical; Epigenomics; Histones; Humans; Iron; Iron Chelating Agents; Methylation; Mice; Mitochondria; Neoplasms; Reactive Oxygen Species; Receptors, Antigen, T-Cell; Rhenium; RNA Polymerase II; Signal Transduction | 2020 |
Functionalizing Collagen with Vessel-Penetrating Two-Photon Phosphorescence Probes: A New In Vivo Strategy to Map Oxygen Concentration in Tumor Microenvironment and Tissue Ischemia.
Topics: Blood Vessels; Collagen; Humans; Iridium; Luminescent Agents; Microscopy, Confocal; Neoplasms; Oxygen; Photons; Rhenium; Tumor Hypoxia; Tumor Microenvironment | 2021 |
Neutron-activatable needles for radionuclide therapy of solid tumors.
Topics: Brachytherapy; Coated Materials, Biocompatible; Drug Delivery Systems; Equipment Design; Holmium; Humans; Molybdenum; Needles; Neoplasms; Neutrons; Rhenium; Titanium; Transdermal Patch | 2017 |
In Vitro Anticancer Activity and in Vivo Biodistribution of Rhenium(I) Tricarbonyl Aqua Complexes.
Topics: Animals; Antineoplastic Agents; Cell Cycle; Cell Line, Tumor; Cell Survival; Coordination Complexes; Crystallography, X-Ray; HeLa Cells; Humans; Mice, Inbred C57BL; Models, Molecular; Neoplasms; Reactive Oxygen Species; Rhenium; Tissue Distribution | 2017 |
Trackable Metallodrugs Combining Luminescent Re(I) and Bioactive Au(I) Fragments.
Topics: 2,2'-Dipyridyl; A549 Cells; Antineoplastic Agents; Cell Proliferation; Coordination Complexes; Gold; Humans; Ligands; Luminescence; Luminescent Agents; Neoplasms; Optical Imaging; Rhenium | 2017 |
Design and synthesis of tumor-targeting theranostic drug conjugates for SPECT and PET imaging studies.
Topics: Animals; Biotin; Chelating Agents; Click Chemistry; Copper; Drug Design; Neoplasms; Positron-Emission Tomography; Rhenium; Taxoids; Theranostic Nanomedicine; Tomography, Emission-Computed, Single-Photon; Triazines | 2018 |
Targeted reversal and phosphorescence lifetime imaging of cancer cell metabolism via a theranostic rhenium(I)-DCA conjugate.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Coordination Complexes; Dichloroacetic Acid; Embryo, Nonmammalian; Fluorescent Dyes; Glucose; Glycolysis; Humans; Mice, Nude; Mitochondria; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Optical Imaging; Oxidation-Reduction; Rhenium; Theranostic Nanomedicine; Zebrafish | 2018 |
A dual signal amplification nanosensor based on SERS technology for detection of tumor-related DNA.
Topics: Coordination Complexes; DNA, Neoplasm; Gold; Humans; Lasers; Nanotubes; Neoplasms; Osmium; Rhenium; Silicon Dioxide; Spectrum Analysis, Raman | 2019 |
Towards cancer cell-specific phototoxic organometallic rhenium(I) complexes.
Topics: Bombesin; Cell Line; Cell Survival; Drug Delivery Systems; HeLa Cells; Humans; Neoplasms; Nuclear Localization Signals; Organometallic Compounds; Photosensitizing Agents; Rhenium; Singlet Oxygen | 2014 |
Isostructural Re(I)/(99m)Tc(I) tricarbonyl complexes for cancer theranostics.
Topics: Humans; Neoplasms; Organotechnetium Compounds; Rhenium; Theranostic Nanomedicine | 2015 |
Monte Carlo Calculation of Radioimmunotherapy with (90)Y-, (177)Lu-, (131)I-, (124)I-, and (188)Re-Nanoobjects: Choice of the Best Radionuclide for Solid Tumour Treatment by Using TCP and NTCP Concepts.
Topics: Algorithms; Antibodies, Monoclonal; Carcinoma, Non-Small-Cell Lung; Computer Simulation; Humans; Iodine Radioisotopes; Lung; Lung Neoplasms; Lutetium; Models, Statistical; Monte Carlo Method; Nanomedicine; Neoplasms; Radiation Pneumonitis; Radioimmunotherapy; Radioisotopes; Radiotherapy Planning, Computer-Assisted; Rhenium; Yttrium Radioisotopes | 2015 |
Cytotoxic Effects of PEGylated Anti-EGFR Immunoliposomes Combined with Doxorubicin and Rhenium-188 Against Cancer Cells.
Topics: Antibodies, Monoclonal; Cell Death; Cell Line, Tumor; Combined Modality Therapy; Doxorubicin; Endocytosis; ErbB Receptors; Humans; Liposomes; Microscopy, Fluorescence; Neoplasms; Polyethylene Glycols; Rhenium; Time Factors | 2015 |
(99m)Tc-Cyclopentadienyl Tricarbonyl Chelate-Labeled Compounds as Selective Sigma-2 Receptor Ligands for Tumor Imaging.
Topics: Animals; Cell Line, Tumor; Chelating Agents; Glioma; Humans; Ligands; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Molecular Conformation; Neoplasms; Organometallic Compounds; Prostatic Neoplasms; Receptors, sigma; Rhenium; Technetium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2016 |
Mono- and Dinuclear Phosphorescent Rhenium(I) Complexes: Impact of Subcellular Localization on Anticancer Mechanisms.
Topics: Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Cell Survival; Crystallography, X-Ray; Humans; Membrane Potential, Mitochondrial; Models, Molecular; Neoplasms; Organometallic Compounds; Reactive Oxygen Species; Rhenium; Transcriptome | 2016 |
A stable neurotensin-based radiopharmaceutical for targeted imaging and therapy of neurotensin receptor-positive tumours.
Topics: Amino Acid Sequence; Animals; Biological Transport; Cell Line, Tumor; Half-Life; Humans; Mice; Molecular Weight; Neoplasms; Neurotensin; Organotechnetium Compounds; Radioisotopes; Radiopharmaceuticals; Receptors, Neurotensin; Rhenium; Staining and Labeling; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2009 |
Radiobiological considerations for radioembolization with 188Re-microspheres.
Topics: Embolization, Therapeutic; Microspheres; Neoplasms; Radiation Dosage; Radiobiology; Radioisotopes; Rhenium | 2009 |
Fluorine and rhenium substituted ghrelin analogues as potential imaging probes for the growth hormone secretagogue receptor.
Topics: Amino Acid Sequence; Animals; CHO Cells; Cricetinae; Cricetulus; Cyclopentanes; Fluorine; Fluorine Radioisotopes; Ghrelin; Humans; Isotopes; Molecular Sequence Data; Neoplasms; Organometallic Compounds; Peptide Fragments; Radioligand Assay; Radiopharmaceuticals; Receptors, Ghrelin; Rhenium; Tomography, Emission-Computed, Single-Photon | 2009 |
Imaging targeted at tumor with (188)Re-labeled VEGF(189) exon 6-encoded peptide and effects of the transfecting truncated KDR gene in tumor-bearing nude mice.
Topics: Adenoviridae; Amino Acid Sequence; Animals; Binding, Competitive; Cell Line, Tumor; Chromatography, High Pressure Liquid; Exons; Gene Deletion; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Oligopeptides; Rabbits; Radioisotopes; Rhenium; Tissue Distribution; Tomography, Emission-Computed, Single-Photon; Transfection; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2009 |
Radiopharmaceutical tracking of particles injected into tumors: a model to study clearance kinetics.
Topics: Animals; Carcinoma 256, Walker; Epinephrine; Female; Humans; Injections, Intralesional; Kidney; Liver; Lung; Microspheres; Models, Animal; Neoplasms; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Rhenium; Sarcoma, Yoshida; Serum Albumin; Spleen; Sulfur; Tissue Distribution | 2009 |
Preparation and evaluation of 186/188Re-labeled antibody (A7) for radioimmunotherapy with rhenium(I) tricarbonyl core as a chelate site.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Chelating Agents; Drug Stability; Female; Humans; Immunoglobulin G; Mice; Neoplasms; Organometallic Compounds; Radioimmunotherapy; Radioisotopes; Rhenium; Tissue Distribution | 2009 |
Radiolabeling RGD peptide and preliminary biodistribution evaluation in mice bearing S180 tumors.
Topics: Amino Acid Sequence; Animals; Cattle; Integrin alphaVbeta3; Mice; Neoplasms; Oligopeptides; Protein Stability; Radioisotopes; Rhenium; Tissue Distribution | 2010 |
Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
Topics: Animals; Cell Line, Tumor; Click Chemistry; Contrast Media; Coordination Complexes; Diagnostic Imaging; Humans; Ketones; Ligands; Metronidazole; Mice; Mice, Inbred C57BL; Neoplasms; Nitroimidazoles; Protein Binding; Proteins; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium; Tissue Distribution | 2012 |
Biodistribution of 131I-, 186Re-, 177Lu-, and 88Y-labeled hLL2 (Epratuzumab) in nude mice with CD22-positive lymphoma.
Topics: Analysis of Variance; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, CD; Antigens, Differentiation, B-Lymphocyte; Cell Adhesion Molecules; Duodenum; Female; Femur; Humans; Iodine Radioisotopes; Kidney; Lectins; Liver; Lung; Lutetium; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Muscles; Neoplasm Transplantation; Neoplasms; Radioimmunotherapy; Radioisotopes; Rhenium; Sialic Acid Binding Ig-like Lectin 2; Spleen; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Yttrium Radioisotopes | 2003 |
186Re and high-specific-activity 177Lu available in North America.
Topics: Animals; Humans; Lutetium; Neoplasms; North America; Radioisotopes; Radiopharmaceuticals; Rhenium | 2004 |
A kit for labeling of [188Re] human serum albumin microspheres for therapeutic use in nuclear medicine.
Topics: Humans; Microspheres; Neoplasms; Radioisotopes; Rhenium; Serum Albumin | 2005 |
[beta-Radiation exposure with (188)Re-labelled pharmaceuticals].
Topics: Beta Particles; Fingers; Humans; Neoplasms; Radiopharmaceuticals; Radiotherapy Dosage; Rhenium; Thermoluminescent Dosimetry | 2005 |
Preparation and characterization of radioactive dirhenium decacarbonyl-loaded PLLA nanoparticles for radionuclide intra-tumoral therapy.
Topics: Absorptiometry, Photon; Algorithms; Calorimetry, Differential Scanning; Emulsions; Magnetic Resonance Spectroscopy; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Nanoparticles; Neoplasms; Neutron Activation Analysis; Particle Size; Polyesters; Polyvinyl Alcohol; Radioisotopes; Radiopharmaceuticals; Rhenium; Solvents; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2007 |
Isostructural folate conjugates radiolabeled with the matched pair 99mTc/188Re: a potential strategy for diagnosis and therapy of folate receptor-positive tumors.
Topics: Animals; Antineoplastic Agents; Buffers; Carrier Proteins; Female; Folate Receptors, GPI-Anchored; Folic Acid; Folic Acid Antagonists; Glutamates; Guanine; Humans; Isotope Labeling; KB Cells; Kidney; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Pemetrexed; Phosphates; Radioisotopes; Radiopharmaceuticals; Receptors, Cell Surface; Rhenium; Technetium; Tissue Distribution | 2007 |
[Clinical use of 99mTc-rhenium sulfide colloid for lymphoscintigraphy (author's transl)].
Topics: Humans; Lymph Nodes; Neoplasms; Radionuclide Imaging; Rhenium; Sulfur; Technetium; Technetium Tc 99m Sulfur Colloid | 1981 |
1996 SNM annual meeting: medical problem solving.
Topics: Artifacts; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Colorectal Neoplasms; Contrast Media; Dementia; Deoxyglucose; Eye Neoplasms; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genetic Therapy; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Melanoma; Neoplasms; Radioisotopes; Radiotherapy; Rhenium; Societies, Medical; Technetium; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon | 1996 |
Synthesis of bombesin analogues for radiolabeling with rhenium-188.
Topics: 3T3 Cells; Animals; Bombesin; Humans; Isotope Labeling; Male; Mice; Neoplasms; Receptors, Bombesin; Rhenium | 1997 |
Marrow toxicity and radiation absorbed dose estimates from rhenium-186-labeled monoclonal antibody.
Topics: Animals; Bone Marrow; Humans; Mice; Neoplasms; Radiation Dosage; Radioimmunotherapy; Radioisotopes; Rhenium | 1998 |
Biotherapy of cancer marches on!
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Breast Neoplasms; Female; Humans; Neoplasms; Radioimmunotherapy; Radiopharmaceuticals; Rhenium; Trastuzumab | 1998 |
How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Neoplasms; Radioimmunotherapy; Radioisotopes; Radiotherapy Dosage; Recombinant Fusion Proteins; Rhenium | 2000 |
An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy.
Topics: Animals; Brachytherapy; Copper Radioisotopes; Drug Carriers; Iodine Radioisotopes; Liposomes; Mice; Neoplasms; Particle Size; Radiation Dosage; Radioisotopes; Rhenium; Tissue Distribution; Yttrium Radioisotopes | 2001 |
Tumor targeting properties of monoclonal antibodies with different affinity for target antigen CD44V6 in nude mice bearing head-and-neck cancer xenografts.
Topics: Animals; Antibodies, Monoclonal; Antigen-Antibody Reactions; Dose-Response Relationship, Drug; Epitopes; Glycoproteins; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunotherapy; Inhibitory Concentration 50; Kinetics; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms; Protein Binding; Protein Structure, Tertiary; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Surface Plasmon Resonance; Time Factors | 2002 |
Synthesis and characterization of [186Re]rhenium(V)dimercaptosuccinic acid: a possible tumour radiotherapy agent.
Topics: Humans; Indicators and Reagents; Isomerism; Molecular Structure; Neoplasms; Organometallic Compounds; Radioisotopes; Rhenium; Succimer | 1991 |
Radiolabeled biomolecules with 186Re: potential for radioimmunotherapy.
Topics: Antibodies, Monoclonal; Humans; Indicators and Reagents; Neoplasms; Pentetic Acid; Radioisotopes; Rhenium; Serum Albumin | 1986 |